Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples

被引：25
作者：
Latsuzbaia, Ardashel [1 ]
Tapp, Jessica [1 ]
Trung Nguyen [1 ]
Fischer, Marc [2 ]
Arbyn, Marc [3 ]
Weyers, Steven [4 ]
Mossong, Joel [1 ]
机构：
[1] Lab Natl Sante, Surveillance & Epidemiol Infect Dis, Dudelange, Luxembourg
[2] Dept Med, Lab Natl Sante, Dudelange, Luxembourg
[3] Sci Inst Publ Hlth, Belgian Canc Ctr, Unit Canc Epidemiol, Brussels, Belgium
[4] Ghent Univ Hosp, Dept Obstet & Gynecol, Ghent, Belgium
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2016年 / 85卷 / 03期
关键词：
Anyplex II HPV28; Euroarray HPV; Human papilloma virus; HPV genotyping; Method comparison; Vaccine monitoring; HUMAN-PAPILLOMAVIRUS; CANCER; INFECTION; WOMEN; ASSAY; RISK;
D O I：
10.1016/j.diagmicrobio.2016.04.011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Analytically accurate human papillomavirus (HPV) genotyping methods are required to assess the impact of HPV vaccination. The aim of this study was to evaluate the analytical performance of Anyplex II HPV28 (Seegene, Korea) and Euroarray HPV (Euroimmun, Germany) genotyping kits, for conducting a future HPV vaccine efficacy monitoring study in Luxembourg. A total number of 150 cervical swabs were collected from women with mean age 31.4 years. Agreements for detecting any HPV between Aptima/Anyplex (88.0%) and Aptima/Euroarray (90.7%) were similar. Agreement of Anyplex/EuroArray with Aptima was higher for Genotypes 16, 18 or 45 than for the other 11 HPVs. The average number of HPV genotypes detected per sample was similar with 2.6 and 2.5, for Anyplex and EuroArray, respectively. In conclusion, Anyplex and Euroarray showed high agreement in general and in particular for detecting genotypes contained in HPV vaccines. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码：318 / 322
页数：5
相关论文
共 30 条
[1]   Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? [J].
Arbyn, M. ;
Snijders, P. J. F. ;
Meijer, C. J. L. M. ;
Berkhof, J. ;
Cuschieri, K. ;
Kocjan, B. J. ;
Poljak, M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (09) :817-826
[2]   Introduction of Human Papillomavirus Vaccination in Belgium, Luxembourg and the Netherlands [J].
Arbyn, M. ;
Simoens, C. ;
Van Damme, P. ;
Scharpantgen, A. ;
Meijer, C. J. L. M. ;
Beutels, P. .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2010, 70 (04) :224-232
[3]   VALGENT: A protocol for clinical validation of human papillomavirus assays [J].
Arbyn, Marc ;
Depuydt, Christophe ;
Benoy, Ina ;
Bogers, Johannes ;
Cuschieri, Kate ;
Schmitt, Markus ;
Pawlita, Michael ;
Geraets, Daan ;
Heard, Isabelle ;
Gheit, Tarik ;
Tommasino, Massimo ;
Poljak, Mario ;
Bonde, Jesper ;
Quint, Wim .
JOURNAL OF CLINICAL VIROLOGY, 2016, 76 :S14-S21
[4]   Are 20 human papillomavirus types causing cervical cancer? [J].
Arbyn, Marc ;
Tommasino, Massimo ;
Depuydt, Christophe ;
Dillner, Joakim .
JOURNAL OF PATHOLOGY, 2014, 234 (04) :431-435
[5]   Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer [J].
Arbyn, Marc ;
Ronco, Guglielmo ;
Anttila, Ahti ;
Meijer, Chris J. L. M. ;
Poljak, Mario ;
Ogilvie, Gina ;
Koliopoulos, George ;
Naucler, Pontus ;
Sankaranarayanan, Rengaswamy ;
Peto, Julian .
VACCINE, 2012, 30 :F88-F99
[6]   A review of human carcinogens-Part B: biological agents [J].
Bouvard, Veronique ;
Baan, Robert ;
Straif, Kurt ;
Grosse, Yann ;
Secretan, Beatrice ;
El Ghissassi, Fatiha ;
Benbrahim-Tallaa, Lamia ;
Guha, Neela ;
Freeman, Crystal ;
Galichet, Laurent ;
Cogliano, Vincent .
LANCET ONCOLOGY, 2009, 10 (04) :321-322
[7]   Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease [J].
Chaturvedi, Anil K. ;
Katki, Hormuzd A. ;
Hildesheim, Allan ;
Cecilia Rodriguez, Ana ;
Quint, Wim ;
Schiffman, Mark ;
Van Doorn, Leen-Jan ;
Porras, Carolina ;
Wacholder, Sholom ;
Gonzalez, Paula ;
Sherman, Mark E. ;
Herrero, Rolando .
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (07) :910-920
[8]   Judging the carcinogenicity of rare human papillomavirus types [J].
Combes, Jean-Damien ;
Guan, Peng ;
Franceschi, Silvia ;
Clifford, Gary M. .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (03) :740-742
[9]   The integration of HPV-18 DNA in cervical carcinoma [J].
Corden, SA ;
Sant-Cassia, LJ ;
Easton, AJ ;
Morris, AG .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1999, 52 (05) :275-282
[10]   Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study [J].
de Sanjose, Silvia ;
Quint, Wim G. V. ;
Alemany, Laia ;
Geraets, Daan T. ;
Ellen Klaustermeier, Jo ;
Lloveras, Belen ;
Tous, Sara ;
Felix, Ana ;
Eduardo Bravo, Luis ;
Shin, Hai-Rim ;
Vallejos, Carlos S. ;
Alonso de Ruiz, Patricia ;
Lima, Marcus Aurelho ;
Guimera, Nuria ;
Clavero, Omar ;
Alejo, Maria ;
Llombart-Bosch, Antonio ;
Cheng-Yang, Chou ;
Alejandro Tatti, Silvio ;
Kasamatsu, Elena ;
Iljazovic, Ermina ;
Odida, Michael ;
Prado, Rodrigo ;
Seoud, Muhieddine ;
Grce, Magdalena ;
Usubutun, Alp ;
Jain, Asha ;
Hernandez Suarez, Gustavo Adolfo ;
Estuardo Lombardi, Luis ;
Banjo, Aekunbiola ;
Menendez, Clara ;
Javier Domingo, Efren ;
Velasco, Julio ;
Nessa, Ashrafun ;
Chichareon, Saibua C. Bunnag ;
Qiao, You Lin ;
Lerma, Enrique ;
Garland, Suzanne M. ;
Sasagawa, Toshiyuki ;
Ferrera, Annabelle ;
Hammouda, Doudja ;
Mariani, Luciano ;
Pelayo, Adela ;
Steiner, Ivo ;
Oliva, Esther ;
Meijer, Chris J. L. M. ;
Al-Jassar, Waleed Fahad ;
Cruz, Eugenia ;
Wright, Thomas C. ;
Puras, Ana .
LANCET ONCOLOGY, 2010, 11 (11) :1048-1056
123